Zhan, Ling
Feng, Hong-fang
Yu, Xi-zi
Li, Ling-rui
Song, Jun-long
Tu, Yi
Yuan, Jing-ping
Chen, Chuang
Sun, Sheng-rong
Funding for this research was provided by:
the National Natural Science Foundation of China (81302314)
Hubei Provincial Natural Science Foundation (2019AEA170)
Article History
Received: 7 January 2021
Accepted: 5 May 2022
First Online: 20 June 2022
Declarations
:
: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). All participants in this research were diagnosed as papillary thyroid carcinomas at the Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, P.R. China. The study was approved by Institutional Ethics Review Committee of this hospital (No. 2042019kf0229). Written informed consent was obtained from all patients who participated in this research.
: All patients who participated in this research signed the informed consent and had complete clinical data.
: The authors declare that there are no competing interest.